Siga Technologies (SIGA) Share-based Compensation (2010 - 2025)
Siga Technologies' (SIGA) quarterly Share-based Compensation came in at $774104.0 in Q3 2025, down 4.87% YoY from $813774.0 in Q3 2024, and down 37.29% on a QoQ basis from $1.2 million in Q2 2025.
Siga Technologies (SIGA) Share-based Compensation (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Share-based Compensation data on file, last reported at $774104.0 in Q3 2025.
- Quarterly Share-based Compensation fell 4.87% year-over-year to $774104.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.7 million (up 8.53% YoY) and the FY2024 annual result came in at $3.6 million, up 73.34% from the prior year.
- Share-based Compensation declined to $774104.0 in Q3 2025, from $1.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q2 2025 to a low of $243503.0 in Q3 2021.
- A 5-year average of $618471.8 and a median of $510007.0 in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation plunged 36.06% — and 2024, when it surged 176.47%.
- Tracing SIGA's Share-based Compensation over 5 years: stood at $342680.0 in 2021, then soared by 106.35% to $707107.0 in 2022, then declined by 27.87% to $510007.0 in 2023, then soared by 49.82% to $764070.0 in 2024, then grew by 1.31% to $774104.0 in 2025.
- The last three Share-based Compensation figures came in at $774104.0 (Q3 2025), $1.2 million (Q2 2025), and $902280.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Siga Technologies | 210.16 Mn | 55.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 774,104.00 |
| Sep 30, 2025 | 774,104.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 902,280.00 |
| Mar 31, 2025 | 902,280.00 |
| Dec 31, 2024 | 764,070.00 |
| Dec 31, 2024 | 764,070.00 |
| Sep 30, 2024 | 813,774.00 |
| Sep 30, 2024 | 813,774.00 |
| Jun 30, 2024 | 932,287.00 |
| Jun 30, 2024 | 932,287.00 |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 510,007.00 |
| Dec 31, 2023 | 510,007.00 |
| Sep 30, 2023 | 459,823.00 |
| Sep 30, 2023 | 459,823.00 |
| Jun 30, 2023 | 721,440.00 |
| Jun 30, 2023 | 721,440.00 |